Olumiant is a prescription medication that is a Janus kinase (JAK) inhibitor, and is used to treat adults with severe alopecia areata. You could regrow your hair. Olumiant showed significant hair regrowth in some adults, resulting in 80% scalp coverage at 36 weeks.

Olumiant is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with severe alopecia areata (AA). Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants.

2025年1月8日 · Alopecia areata causes hair loss on the scalp or other body parts such as the eyebrows. New treatments like Olumiant offer hope for some people. This FDA-approved medicine works in unique...

Baricitinib, an oral, reversible, selective JAK1/JAK2 inhibitor, was shown to be superior to placebo on hair growth after 36 weeks of treatment in adults with severe AA in a phase 2 trial and recently in two phase 3 trials (BRAVE-AA1 and BRAVE-AA2).

2017年3月16日 · Two main studies in 1200 adults with severe alopecia areata (experiencing loss of at least 50% of scalp hair) showed that Olumiant was effective at reducing hair loss compared to placebo.

Olumiant (baricitinib) is an oral Janus kinase (JAK) inhibitor approved by the U.S. Food and Drug Administration (FDA) for adults with severe alopecia areata (AA) (1). The FDA approved Olumiant for AA in June 2022. In clinical trials of baricitinib, severe AA …

2023年10月12日 · Olumiant is an oral medication taken by mouth once per day, with or without food. Your doctor will determine the best dose for you. The recommended dose of Olumiant for alopecia areata is 2 mg per day. Your healthcare provider may increase your dose to 4 mg per day if you do not have a good response at the 2 mg dose.

2025年2月6日 · Olumiant (baricitinib) is a prescription drug used to treat severe alopecia areata. It’s typically used when hair loss from this condition affects more than 50% of the scalp.

2025年2月3日 · However, two new studies suggest that the JAK inhibitor Olumiant can promote hair regrowth even in those with sustained, severe alopecia areata. The FDA’s approval of Olumiant is a breakthrough for US patients with severe alopecia areata. What causes alopecia areata? What is Olumiant? How does Olumiant work?

Baricitinib (Olumiant ® ), a Janus kinase (JAK) inhibitor, is the first drug approved for the treatment of severe alopecia areata in the USA and the EU. Severe alopecia areata is usually difficult to treat and relapse is common. Patients with this disorder are more likely to suffer from anxiety and depression.